IL18 and ulcerative colitis: Moreover, the ability of MCC950 to suppress both translational and transcriptional IL-1β and IL-18 of canonical and noncanonical NLRP3 inflammasome in the colon may be promising in inflammatory intestinal diseases other than ulcerative colitis.